Know Labs Inc (KNW) Actualités

Form 8-K - Current report

Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

A Plan for Compliance and Activities to Increase Know Labs Valuation have been Undertaken Know Labs, Inc. (NYSE American: KNW) (the “Company” or...

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Know Labs Study Published in IEEE Sensors Journal

Peer-reviewed journal publication validates the novelty of Know Labs’ proprietary radiofrequency (RF) dielectric sensor and its application for...

Form 8-K - Current report

Know Labs, Inc. Announces $1.655 Million Public Offering

Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced that it...

Know Labs, Inc. Reports Third Quarter FY 2024 Results

Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the...

Form 8-K - Current report

 Know Labs, Inc. Announces Closing of $3.445 Million Public Offering

Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing...

Form DEF 14A - Other definitive proxy statements

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness